<?xml version="1.0" encoding="UTF-8"?>
<ref id="trf16015-bib-0005">
 <label>5</label>
 <mixed-citation publication-type="miscellaneous" id="trf16015-cit-0005">
  <collab collab-type="authors">Centers for Disease Control (CDC)</collab> . Recommendations for Investigational COVID‚Äê19 Convalescent Plasma. Version updated May 1, 
  <year>2020</year>
  <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma</ext-link>. Accessed May 14, 2020.
 </mixed-citation>
</ref>
